BioPharmSignal logoBioPharmSignal

Biotech News

Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B

Integra LifeSciences (IART)Integra LifeSciencesCommercial

PRINCETON, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the launch of a proposed $600 million seven-year Senior Secured Term Loan B as part of a broader refinancing transaction.

Related news

IARTIntegra LifeSciences2026-10-02 12:05 EST

Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance

IARTIntegra LifeSciences2026-09-29 12:30 EST

Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry

ADPTAdaptive Biotechnologies2026-09-25 12:03 EST

Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure

HYPRHyperfine2026-08-26 12:15 EST

Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans

ICUSeaStar Medical2026-10-05 12:00 EST

SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds

CVRXCVRx2026-08-25 12:00 EST

CVRx Responds to Letter from Pointillist Family Office

CVRXCVRx2026-09-21 20:08 EST

CVRx Appoints John Landry as Chief Financial Officer

VTAKCatheter Precision2026-09-17 12:00 EST

Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil

PAVMPAVmed2026-08-05 12:46 EST

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

PAVMPAVmed2026-08-04 12:30 EST

Lucid Diagnostics to Participate in Upcoming Investor Conferences

View all latest news

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...

Recent company news

IARTIntegra LifeSciences2026-10-02 12:05 EST

Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance

IARTIntegra LifeSciences2026-10-02 12:00 EST

Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B

IARTIntegra LifeSciences2026-09-29 12:30 EST

Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry

IARTIntegra LifeSciences2026-09-25 13:05 EST

Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026

IARTIntegra LifeSciences2026-09-04 13:15 EST

Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference

Stock data

Close
16.09 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States